Cardenas A, Thomas K, Broden M, Ferraro N, Pires M, John C
mBio. 2024; 15(5):e0011924.
PMID: 38587424
PMC: 11078009.
DOI: 10.1128/mbio.00119-24.
Tzeng Y, Sannigrahi S, Borrow R, Stephens D
Front Immunol. 2024; 15:1350344.
PMID: 38440731
PMC: 10909805.
DOI: 10.3389/fimmu.2024.1350344.
Cardenas A, Thomas K, Broden M, Ferraro N, John C, Pires M
bioRxiv. 2024; .
PMID: 38293026
PMC: 10827150.
DOI: 10.1101/2024.01.17.576097.
Shaughnessy J, Chabeda A, Tran Y, Zheng B, Nowak N, Steffens C
Front Immunol. 2022; 13:975676.
PMID: 36110842
PMC: 9468773.
DOI: 10.3389/fimmu.2022.975676.
Saha S, Khan N, Comi T, Verhagen A, Sasmal A, Diaz S
Mol Biol Evol. 2022; 39(8).
PMID: 35809046
PMC: 9356730.
DOI: 10.1093/molbev/msac151.
Meningococcal Detoxified Outer Membrane Vesicle Vaccines Enhance Gonococcal Clearance in a Murine Infection Model.
Matthias K, Connolly K, Begum A, Jerse A, Macintyre A, Sempowski G
J Infect Dis. 2021; 225(4):650-660.
PMID: 34498079
PMC: 8844591.
DOI: 10.1093/infdis/jiab450.
Development of Complement Factor H-Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant .
Shaughnessy J, Tran Y, Zheng B, DeOliveira R, Gulati S, Song W
Front Immunol. 2020; 11:583305.
PMID: 33193396
PMC: 7649208.
DOI: 10.3389/fimmu.2020.583305.
Modulation of phagocytosis-induced cell death of human neutrophils by Neisseria gonorrhoeae.
Cho C, Teghanemt A, Apicella M, Nauseef W
J Leukoc Biol. 2020; 108(5):1543-1553.
PMID: 32977356
PMC: 7859830.
DOI: 10.1002/JLB.4MA0820-649R.
Therapeutic CMP-Nonulosonates against Multidrug-Resistant .
Gulati S, Schoenhofen I, Lindhout-Djukic T, Schur M, Landig C, Saha S
J Immunol. 2020; 204(12):3283-3295.
PMID: 32434942
PMC: 7321800.
DOI: 10.4049/jimmunol.1901398.
Bypassing Phase Variation of Lipooligosaccharide (LOS): Using Heptose 1 Glycan Mutants To Establish Widespread Efficacy of Gonococcal Anti-LOS Monoclonal Antibody 2C7.
Chakraborti S, Gulati S, Zheng B, Beurskens F, Schuurman J, Rice P
Infect Immun. 2019; 88(2).
PMID: 31818965
PMC: 6977115.
DOI: 10.1128/IAI.00862-19.
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
Gulati S, Shaughnessy J, Ram S, Rice P
Front Immunol. 2019; 10:321.
PMID: 30873172
PMC: 6400993.
DOI: 10.3389/fimmu.2019.00321.
Role of Gonococcal Neisserial Surface Protein A (NspA) in Serum Resistance and Comparison of Its Factor H Binding Properties with Those of Its Meningococcal Counterpart.
Lewis L, Rice P, Ram S
Infect Immun. 2018; 87(2).
PMID: 30510105
PMC: 6346132.
DOI: 10.1128/IAI.00658-18.
Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against .
Shaughnessy J, Lewis L, Zheng B, Carr C, Bass I, Gulati S
J Immunol. 2018; 201(9):2700-2709.
PMID: 30266769
PMC: 6200640.
DOI: 10.4049/jimmunol.1701666.
Nontypeable Haemophilus influenzae Lipooligosaccharide Expresses a Terminal Ketodeoxyoctanoate , Which Can Be Used as a Target for Bactericidal Antibody.
Apicella M, Coffin J, Ketterer M, Post D, Day C, Jen F
mBio. 2018; 9(4).
PMID: 30065093
PMC: 6069110.
DOI: 10.1128/mBio.01401-18.
A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.
Ram S, Gulati S, Lewis L, Chakraborti S, Zheng B, DeOliveira R
Infect Immun. 2018; 86(8).
PMID: 29844237
PMC: 6056883.
DOI: 10.1128/IAI.00285-18.
Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.
Ram S, Shaughnessy J, de Oliveira R, Lewis L, Gulati S, Rice P
Pathog Dis. 2017; 75(4).
PMID: 28460033
PMC: 5449626.
DOI: 10.1093/femspd/ftx049.
Desialylation of Neisseria gonorrhoeae Lipooligosaccharide by Cervicovaginal Microbiome Sialidases: The Potential for Enhancing Infectivity in Men.
Ketterer M, Rice P, Gulati S, Kiel S, Byerly L, Fortenberry J
J Infect Dis. 2016; 214(11):1621-1628.
PMID: 27471322
PMC: 6392504.
DOI: 10.1093/infdis/jiw329.
Phase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae Lipooligosaccharide.
Chakraborti S, Lewis L, Cox A, St Michael F, Li J, Rice P
J Immunol. 2016; 196(11):4576-86.
PMID: 27183633
PMC: 4875794.
DOI: 10.4049/jimmunol.1600374.
A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.
Shaughnessy J, Gulati S, Agarwal S, Unemo M, Ohnishi M, Su X
J Immunol. 2016; 196(4):1732-40.
PMID: 26773149
PMC: 4744571.
DOI: 10.4049/jimmunol.1500292.
α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.
Lewis L, Gulati S, Burrowes E, Zheng B, Ram S, Rice P
mBio. 2015; 6(1).
PMID: 25650401
PMC: 4324315.
DOI: 10.1128/mBio.02465-14.